Perception Capital Ii's Quick Ratio

SPEC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth

Within Scientific & Technical Instruments industry Perception Capital Corp Ii booked the highest Quick Ratio than Perception Capital Ii in the . While total ranking remained the same in the compared to the third quarter 2023 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents SPEC�s has?
What are SPEC�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SPEC Quick Ratio	(Jun 30 2024) 2024	(Sep 30 2023) Q3	(Jun 30 2023)	(Mar 31 2023)	(Sep 30 2022)
Y / Y Current Liabilities Change	2033.72 %	2060.02 %	1879.54 %	2240.13 %	-
Y / Y Cash & cash equivalent Change	-	-	-84.17 %	-	-
Quick Ratio MRQ	-	-	0.01	0.22	0.18
SPEC's Total Ranking	#	#	#	#	#
Seq. Current Liabilities Change	39.95 %	35.61 %	20.79 %	830.76 %	41.68 %
Seq. Cash & cash equivalent Change	-	-	-96.07 %	1011.4 %	-52.36 %

Quick Ratio Company Ranking
Within:	No.
Scientific & Technical Instruments Industry	#
Technology Sector	#
Overall Market	#

Quick Ratio Statistics
High	Average	Low
0	0	0

Financial Statements
Perception Capital Ii's Current Liabilities	$ 22 Millions	Visit SPEC's Balance sheet
Perception Capital Ii's Cash & cash equivalent	$ 0 Millions	Visit SPEC's Balance sheet
Source of SPEC's Sales		Visit SPEC's Sales by Geography

Cumulative Perception Capital Ii's Quick Ratio

SPEC's Quick Ratio for the trailling 12 Months

SPEC Quick Ratio	(Jun 30 2024) 12 Months	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months	(Mar 31 2023) 12 Months	(Sep 30 2022) 12 Months
Y / Y Current Liabilities TTM Growth	2038.62 %	2101.38 %	2204.7 %	2811.8 %	-
Y / Y Cash & cash equivalent TTM Growth	97.09 %	158.21 %	430.47 %	-	-
Quick Ratio TTM	0.04	0.06	0.12	0.27	0.4
Total Ranking TTM	# 4258	# 0	# 4059	# 2715	#
Seq. Current Liabilities TTM Growth	55.27 %	65.33 %	92.17 %	333.52 %	59.83 %
Seq. Cash & cash equivalent TTM Growth	-7.97 %	-14.33 %	-13.69 %	189.63 %	20.57 %

Quick ratio ranking by company, industry and sector >> Back to SPEC Financial Strength Comparisons >> Go to Compare SPEC Quick Ratio to its Competitors

On the trailing twelve months basis Due to unchanged in Current Liabilities in the to $22.25 millions, cumulative Quick Ratio decreased to 0.04 above the SPEC average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Scientific & Technical Instruments industry 19 other companies have achieved higher Quick Ratio than Perception Capital Ii. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2023 from 0 to 4258.

Explain Quick Ratio?
How much Cash & cash equivalents SPEC�s has?
What are SPEC�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Scientific & Technical Instruments Industry	# 20
Technology Sector	# 756
Within the Market	# 4258

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.01	0.01	0.01
(Sep 30 2023)

Companies with similar Quick Ratio in the quarter ending Jun 30 2024, within Scientific & Technical Instruments Industry

Quick Ratio

Jun 30 2024 MRQ Cash & cash equivalent

Jun 30 2024 MRQ Current Liabilities

Date modified: 2026-08-31T19:56:56+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.